SU-F-E-12: Elective International Rotations in Medical Physics Residency Programs

2016 ◽  
Vol 43 (6Part5) ◽  
pp. 3355-3355
Author(s):  
D Brown ◽  
A Mundt ◽  
J Einck ◽  
T Pawlicki
Keyword(s):  
Medical Physics ◽  
Residency Programs

Medical Physics residency programs in nonacademic facilities should affiliate themselves with a university-based program

2011 ◽  
Vol 39 (1) ◽  
pp. 1-3 ◽  
Author(s):  
Jatinder Saini ◽  
Jason R. Sherman ◽  
Colin G. Orton
Keyword(s):  
Medical Physics ◽  
Residency Programs

The Current State of Physics Plan Review Training in Medical Physics Residency Programs in North America

2020 ◽  
Vol 10 (3) ◽  
pp. e166-e172 ◽  
Author(s):  
Leah K. Schubert ◽  
Kristi Hendrickson ◽  
Moyed Miften ◽  
Monica McNulty ◽  
Yevgeniy Y. Vinogradskiy ◽  
...  
Keyword(s):  
North America ◽  
Medical Physics ◽  
Residency Programs ◽  
Current State

scholarly journals Recommended ethics curriculum for medical physics graduate and residency programs: Report of Task Group 159

2010 ◽  
Vol 37 (8) ◽  
pp. 4495-4500 ◽  
Author(s):  
Christopher F. Serago ◽  
Jay W. Burmeister ◽  
Peter B. Dunscombe ◽  
Ashley A. Gale ◽  
William R. Hendee ◽  
...  
Keyword(s):  
Medical Physics ◽  
Task Group ◽  
Residency Programs ◽  
Ethics Curriculum

Senior Medical Students’ Attitudes toward Choosing Residency Programs in Primary Care

1985 ◽  
Vol 1 (4) ◽  
pp. 38-43 ◽  
Author(s):  
Robert R. Franklin ◽  
Pamela A. Samaha ◽  
Janet C. Rice ◽  
Susan M. Igras
Keyword(s):  
Primary Care ◽  
Medical Students ◽  
Residency Programs ◽  
Students Attitudes

Guideline for radioimmunotherapy of rituximab relapsed or refractory CD20+ follicular B-cell nonHodgkin´s lymphoma

2004 ◽  
Vol 43 (05) ◽  
pp. 171-176 ◽  
Author(s):  
T. Behr ◽  
F. Grünwald ◽  
W. H. Knapp ◽  
L. Trümper ◽  
C. von Schilling ◽  
...  
Keyword(s):  
Quality Control ◽  
Quality Management ◽  
Medical Physics ◽  
Essential Elements ◽  
Background Information ◽  
After Care ◽  
Complete Treatment ◽  
Close Cooperation ◽  
Work Up

Summary:This guideline is a prerequisite for the quality management in the treatment of non-Hodgkin-lymphomas using radioimmunotherapy. It is based on an interdisciplinary consensus and contains background information and definitions as well as specified indications and detailed contraindications of treatment. Essential topics are the requirements for institutions performing the therapy. For instance, presence of an expert for medical physics, intense cooperation with all colleagues committed to treatment of lymphomas, and a certificate of instruction in radiochemical labelling and quality control are required. Furthermore, it is specified which patient data have to be available prior to performance of therapy and how the treatment has to be carried out technically. Here, quality control and documentation of labelling are of greatest importance. After treatment, clinical quality control is mandatory (work-up of therapy data and follow-up of patients). Essential elements of follow-up are specified in detail. The complete treatment inclusive after-care has to be realised in close cooperation with those colleagues (haematology-oncology) who propose, in general, radioimmunotherapy under consideration of the development of the disease.

Sign in / Sign up

Export Citation Format

Share Document